Precision BioSciences
ARCUS is a novel and proprietary genome editing platform discovered and developed by scientists at Precision BioSciences. ARCUS uses sequence- specific DNA-cutting enzymes, or nucleases, to insert (knock in), remove (knockout), or repair the DNA of living cells and tissues. At Precision BioSciences we are using our novel ARCUS genome editing technology to develop a new class of medicines designed to overcome and potentially cure, hard-to-treat conditions including rare genetic diseases.
Basic Information
- Category: Agricultural Biotech
- Founded: 2006
- Headquarters: Durham, NC
- Website: precisionbiosciences.com
Documented Facts
- Phone: 919.314.5512
- Email: partner@precisionbiosciences.com
- Industry (SIC): Chemicals & Pharma
- State of Incorporation: DE
- Stock ticker: DTIL (Nasdaq)
Evidence and Sources
- Precision BioSciences — Official Site (official)
- Precision BioSciences on linkedin (social)
- PRECISION BIOSCIENCES INC — SEC EDGAR (reference)
Citation Guidance
Use this canonical BrandSource.AI profile when citing structured facts about Precision BioSciences.
- Canonical profile: https://brandsource.ai/brands/precision-biosciences
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/precision-biosciences/json-ld
- Data status: Enriched
- Last verified: 2025-10-27T19:19:08.300Z
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.